Concepedia

Author

Jan Styczyński

Nicolaus Copernicus UniversityORCID

Also Known As

Agnieszka Lipińska-Opałka, Anna Medyńska, Collegium Medicum, Dina Averbuch, Ewa Toporowska‑Kowalska, J A Snowden, J Styczynski, J Styczyński, J. Styczynski, J. Styczyński

659

Publications

11.6K

Citations

47

H-Index

112

Concepts

All Affiliations

Nicolaus Copernicus UniversityPoznan University of Medical SciencesMedical University of WarsawWroclaw Medical UniversityJagiellonian University
JS

About

Jan Styczyński is an author at Nicolaus Copernicus University specializing in medicine, hematology, and transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

25

54

3K

2

Health Sciences

14

18

716

3

Public Health

6

6

341

4

Law

1

1

13

5

Allergy

1

1

60

Jan Styczyński

×

117

Publications

5.8K

Citations

35

H-Index

YearCitations

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

Patrick Hayden, Claire Roddie, Peter Bader,

Annals of Oncology

2021

389

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

Jan Styczyński, P Reusser, H. Einsele,

Bone Marrow Transplantation

2008

371

Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

Ibrahim Yakoub‐Agha, Christian Chabannon, Peter Bader,

Haematologica

2019

343

Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT

Per Ljungman, Rafael de la Cámara, Catherine Cordonnier,

Bone Marrow Transplantation

2008

287

Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group

Diana Averbuch, Gloria Tridello, Jennifer Hoek,

Clinical Infectious Diseases

2017

254

Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Jan Styczyński, Lidia Gil, Gloria Tridello,

Clinical Infectious Diseases

2013

246

COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey

Per Ljungman, Rafael de la Cámara, Małgorzata Mikulska,

Leukemia

2021

245

Donor Cytomegalovirus Status Influences the Outcome of Allogeneic Stem Cell Transplant: A Study by the European Group for Blood and Marrow Transplantation

Per Ljungman, Ronald Brand, Jennifer Hoek,

Clinical Infectious Diseases

2014

225

Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis

Roni Shouval, Joshua Fein, Myriam Labopin,

The Lancet Haematology

2019

215

Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment

Ondřej Hrušák, Tomáš Kalina, Joshua Wolf,

European Journal of Cancer

2020

195

Page 1